Misplaced Pages

Rohto Pharmaceutical

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Japanese consumer goods company
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2014) (Learn how and when to remove this message)
This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (June 2014) (Learn how and when to remove this message)
This article contains wording that promotes the subject in a subjective manner without imparting real information. Please remove or replace such wording and instead of making proclamations about a subject's importance, use facts and attribution to demonstrate that importance. (November 2024) (Learn how and when to remove this message)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Rohto Pharmaceutical" – news · newspapers · books · scholar · JSTOR (January 2025) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Rohto Pharmaceutical Co., Ltd.
Native nameロート製薬株式会社
Romanized nameRōto Seiyaku kabushiki gaisha
Company typePublic KK
Traded asTYO: 4527
Industry
FoundedHigashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
FounderYasutami Yamada
HeadquartersIkuno-ku, Osaka, Japan
Key people
  • Kunio Yamada (chair and CEO, great-grandson of the founder)
  • Toshiaki Yoshino (president and COO)
Revenue
  • Increase¥120,292 million (FY 2011)
  • ¥115,472 million (FY 2010)
Operating income
  • Increase¥13,624 million (FY 2011)
  • ¥13,105 million (FY 2010)
Net income
  • Increase¥8,184 million (FY 2011)
  • ¥7,966 million (FY 2010)
Total assets
  • Increase¥136,008 million (FY 2011)
  • ¥126,472 million (FY 2010)
Total equity
  • Increase¥83,627 million (FY 2011)
  • ¥77,911 million (FY 2010)
Number of employees5,518 (March 31, 2013)
SubsidiariesMentholatum
Rohto Advanced Research Hong Kong Ltd
Websitewww.rohto.co.jp/global/
Footnotes / references
  1. ^ "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha) is a multinational corporation specializing in fast-moving consumer goods and pharmaceuticals, headquartered in Ikuno-ku, Osaka, Japan. Overall company sales mainly come from skin and eye care products. Other products include cosmetics, food supplements, and over-the-counter medications.

International presence

In 1975, Rohto gained trademark rights to Mentholatum from The Mentholatum Company Inc., allowing the sale of Mentholatum-branded products. Rohto acquired The Mentholatum Company Inc. in June 1988.

Rohto has two production plants in Japan and six across the US, UK, China, Vietnam, Hong Kong, and Indonesia. Rohto entered the Vietnamese market in 1997 to serve the Asia Pacific region. In mid-2010, Rohto entered the Indian and Bangladeshi markets.

In 2024 Rohto Pharmaceutical entered into a strategic partnership with the Austrian Sigmapharm Group. The collaboration aims to expand the production and distribution of ophthalmic drugs and medical products across Europe, with Rohto Pharmaceutical investing nearly €30 million in research, development, production, and sales.

History

Yasutami Yamada (山田 安民) founded "Japanese: 信天堂山田安民薬房, lit.'Shintendo Yamada Yasutami Pharmacy'" in Osaka, on February 22, 1899. ROHTO Pharmaceutical Co. is the largest company in Japan's OTC drugs market. It is a leader in the eye drops market, commanding a 40% share. They introduced "Rohto Eyedrops" in 1909. The name "Rohto" was inspired by August von Rothmund, a German ophthalmologist who was a professor for Toyotaro Inoue (井上 豊太郎, Inoue Toyotarō), a Japanese ophthalmologist.

Brands

Former Rohto logo, used from 2005 to 2024
  • LipIce: Lip Care line
  • Oxy B: Anti-acne products(acquired the OXY Skin Care branding from GlaxoSmithKline in December 2005)
  • Rohto Eyedrops: including Rohto Z!
  • Sunplay: Sunscreen daily sun care and after sun products
  • BodyIce: Deodorant roll-on and mists
  • Mentholatum: Skin care for face and body
  • Selsun: Anti-dandruff shampoo
  • Acnelogy: pimples treatment (Acne + Dermatology. It includes 3 skincare steps (Conditioning Foam, Acne Care Lotion, Concentrate Essence)
  • Hada Labo: Skincare

Head Office and Subsidiaries

  • Rohto Pharmaceutical Co., Ltd. (Japan - Parent Company)
  • Mentholatum Australasia Pty. Ltd.(Australia)
  • The Mentholatum Company Ltd. (UK)
  • The Mentholatum Company of (Canada), Limited
  • The Mentholatum (China) Pharmaceuticals Co., Ltd.
  • Mentholatum Asia Pacific Ltd. (Hong Kong)
  • Rohto Pharma (India) Private Limited
  • Mentholatum de (Mexico), S.A. de C.V.
  • Mentholatum (South Africa) Pty. Ltd.
  • Mentholatum Taiwan Ltd. (Taiwan)
  • PT Rohto Laboratories (Indonesia)
  • Rohto-Mentholatum (Vietnam) Co., Ltd.
  • Rohto-Mentholatum (Malaysia) SDN BHD.
  • Rohto-Mentholatum (Thailand) Ltd.
  • Rohto-Mentholatum (Bangladesh) Limited
  • Rohto-Mentholatum (Cambodia) Co., Ltd.
  • Dax Cosmetics Sp. z o.o. (Poland) Limited

Footnotes

Notes

  1. In Japanese, August von Rothmund was known as アウグスト・フォン・ロートムント (Augusuto-fon-Rōtomunto).

References

  1. ^ "Rohto Pharmaceutical Co Ltd, 4527:TYO profile - FT.com". markets.ft.com. Retrieved 2025-01-09.
  2. ^ Mallett, Daryl F. (2000). "The Mentholatum Company, Inc.". International directory of company histories. Vol. 32. Detroit, Michigan: St. James Press. p. 332. ISBN 9781558623910 – via Internet Archive.
  3. ^ "ROHTO Pharmaceutical". World Economic Forum. Archived from the original on 2024-07-05. Retrieved 2025-01-09.
  4. "Japan's Rohto Pharmaceutical Invests in Austrian Sigmapharm". Vindobona.org | Vienna International News. Retrieved 2025-01-09.

External links

Categories:
Rohto Pharmaceutical Add topic